JFL Life Sciences Ltd
JFLLIFEJFL Life Sciences Ltd
JFLLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹47 cr, stock is ranked 3,008
High RiskStock is 6.27x as volatile as Nifty
43.851.74% (+0.75)
43.851.74% (+0.75)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.47 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.31 | 5.09 | 0.71% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
JFL Life Sciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing of pharmaceutical products
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
34.71
1Y Return
17.66%
Buy Reco %
94.12
Cipla Ltd
PE Ratio
34.93
1Y Return
7.18%
Buy Reco %
65.71
Dr Reddy's Laboratories Ltd
PE Ratio
21.38
1Y Return
28.50%
Buy Reco %
48.65
Mankind Pharma Ltd
PE Ratio
59.30
1Y Return
34.57%
Buy Reco %
45.45
Torrent Pharmaceuticals Ltd
PE Ratio
57.80
1Y Return
31.04%
Buy Reco %
67.86
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31.78 | 30.20 | 32.86 | 34.48 | 44.47 | — | ||||||
Raw Materials | 28.81 | 26.72 | 28.76 | 30.49 | 32.20 | — | ||||||
| Power & Fuel Cost | 0.18 | 0.30 | 0.19 | 0.30 | 0.34 | |||||||
| Employee Cost | 0.96 | 1.25 | 0.98 | 1.43 | 1.83 | |||||||
| Selling & Administrative Expenses | 0.13 | 0.16 | 0.29 | 0.56 | 1.17 | |||||||
| Operating & Other expenses | 0.38 | -0.13 | 0.39 | -4.55 | 3.36 | |||||||
EBITDA | 1.32 | 1.90 | 2.25 | 6.25 | 5.57 | — | ||||||
| Depreciation/Amortization | 0.15 | 0.24 | 0.28 | 0.37 | 0.43 | — | ||||||
| PBIT | 1.17 | 1.66 | 1.97 | 5.88 | 5.14 | — | ||||||
| Interest & Other Items | 0.75 | 1.16 | 1.23 | 2.08 | 1.42 | — | ||||||
| PBT | 0.42 | 0.50 | 0.74 | 3.80 | 3.72 | — | ||||||
| Taxes & Other Items | 0.12 | 0.14 | 0.20 | 0.99 | 0.91 | — | ||||||
| Net Income | 0.30 | 0.36 | 0.54 | 2.81 | 2.81 | — | ||||||
| EPS | 0.55 | 0.65 | 0.90 | 3.88 | 2.95 | — | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| JFL Life Sciences Ltd | 16.87 | 1.47 | — |
| Sun Pharmaceutical Industries Ltd | 34.71 | 4.96 | 0.94% |
| Cipla Ltd | 34.93 | 4.13 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.38 | 4.14 | 0.69% |
Price Comparison
Compare JFLLIFE with any stock or ETFCompare JFLLIFE with any stock or ETF
JFLLIFE
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Sep 2023
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JFLLIFE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant